Atlas Trials

Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

Clinical trial NCT00151398 · COMPLETED

Trial details

NCT number
NCT00151398
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2005-10-06
Primary completion
2008-03-15
Enrollment
229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.